Pharmaceutical Technology's In the Lab eNewsletter
July 02, 2019
Features
14
7
The means to continually improving and enabling the use of artificial intelligence in manufacturing lies in the ability to make data accessible across functions and to contract partners.
July 02, 2019
Features
14
7
The existence of tools today that were not available in the past can help ensure successful product quality and compliance with regulations.
June 28, 2019
New Technology
14
7
The Gyrolab E. coli HCP Kit quantifies host cell protein impurities from Escherichia coli expression systems used in biotherapeutic production.
June 28, 2019
New Technology
14
7
Cytek Biosciences’ Cytek Aurora advanced flow cytometry system uses five lasers to enable seeing more than 30 colors from a single sample.
June 28, 2019
New Technology
14
7
SCIEX added new innovations to improve laboratory workflows and data acquisition from samples.
June 27, 2019
New Technology
14
7
The new flow cytometer system boasts enhanced sensitivity and user-friendly features.
June 27, 2019
New Technology
14
7
The new platform from Berkeley Lights allows scientists to more easily analyze large numbers of cells in a short period of time.
June 27, 2019
New Technology
14
7
The new flow cytometer offers full automation and enhanced software to alleviate bottlenecking.
June 27, 2019
News
14
7
A survey conducted by Agilent Technologies and research and consulting firm Frost & Sullivan revealed pressing issues and objectives experienced by lab leaders around the world.
June 19, 2019
News
14
7
The companies will use emerging data technologies to create a new virtual innovation lab to develop both scientific and commercial solutions.
June 14, 2019
News
14
7
GSK has revealed that it has entered into a five-year collaboration with the University of California to advance genomic research and improve drug discovery.
June 14, 2019
News
14
7
The Michelson Medical Research Foundation and the Human Vaccines Project have awarded three young scientists $150,000 for their novel approaches toward human immune system research.
June 13, 2019
News
14
7
The acquisitions, totaling $50 million, are expected expand Aptar Pharma’s service offerings to support complex product development.